Abstract:This paper deals with a procedure for combined therapies against cancer using oncolytic viruses and inhibitors. Replicating genetically modified adenoviruses infect cancer cells, reproduce inside them and eventually cause their death (lysis). As infected cells die, the viruses inside them are released and then proceed to infect other tumor cells. The successful entry of virus into cancer cells is related to the presence of the coxsackie-adenovirus receptor (CAR). Mitogen-activated protein kinase kinase (known as MEK) inhibitors can promote CAR expression, resulting in enhanced adenovirus entry into cancer cells. However, MEK inhibitors can also cause G1 cell-cycle arrest, inhibiting reproduction of the virus. To design an effective synergistic therapy, the promotion of virus infection must be optimally balanced with inhibition of virus production. We introduce a mathematical model to describe the effects of MEK inhibitors and viruses on tumor cells, and use it to explore the reduction of the tumor size that can be achieved by the combined therapies. Furthermore, we find an optimal dose of inhibitor: P optimal = 1 − µ/δ for a certain initial density of cells (where µ is the removal rate of the dead cells and δ is the death rate of the infected cells). The optimal timing of MEK inhibitors is also numerically studied.

Mathematical Analysis of a Model of a Replication-competent Virus in Tumor Cells

Analysis of a model of a virus that replicates selectively in tumor cells

Simulation of a Model of Tumors with Virus-therapy

A parabolic-hyperbolic free boundary problem modelling tumor treatment with virus

Analysis of a mathematical model for tumor growth with Gibbs–Thomson relation

Mathematical Models Of Tumor Treatment With Virus

The competitive dynamics between tumor cells, a replication-competent virus and an immune response

A mathematical model of tumor-immune interactions incorporated with danger model

Mathematical Analysis on a Diffusion Model Describing the Compatibility Between Two Types of Tumor Cells

Analysis of a mathematical model for tumor therapy with a fusogenic oncolytic virus

Nonlinear Analysis of a Model of Vascular Tumour Growth and Treatment

Mathematical Analysis of a Model of a Vascular Tumor with Chemotherapy

Mathematical modeling of anti-tumor virus therapy: Regimes with complete recovery within the framework of deterministic models

Mathematical analysis of a tumor invasion model—global existence and stability

Analysis of a Tumor-Model Free Boundary Problem with a Nonlinear Boundary Condition

Analysis and simulation of a model for intracellular drug accumulation in tumors

An Elliptic–hyperbolic Free Boundary Problem Modelling Cancer Therapy

A Mathematical Model of Combined Therapies Against Cancer Using Viruses and Inhibitors

Modeling oncolytic virus therapy with distributed delay and non-local diffusion

Analysis of a Mathematical Model for the Growth of Tumors under the Action of External Inhibitors

A FREE BOUNDARY PROBLEM MODELLING CANCER RADIOVIROTHERAPY